Literature DB >> 21398220

Essential role for Ptpn11 in survival of hematopoietic stem and progenitor cells.

Gordon Chan1, Laurene S Cheung, Wentian Yang, Michael Milyavsky, Ashley D Sanders, Shengqing Gu, Wan Xing Hong, Aurora X Liu, Xiaonan Wang, Mary Barbara, Tarun Sharma, Joehleen Gavin, Jeffery L Kutok, Norman N Iscove, Kevin M Shannon, John E Dick, Benjamin G Neel, Benjamin S Braun.   

Abstract

Src homology 2 domain-containing phosphatase 2 (Shp2), encoded by Ptpn11, is a member of the nonreceptor protein-tyrosine phosphatase family, and functions in cell survival, proliferation, migration, and differentiation in many tissues. Here we report that loss of Ptpn11 in murine hematopoietic cells leads to bone marrow aplasia and lethality. Mutant mice show rapid loss of hematopoietic stem cells (HSCs) and immature progenitors of all hematopoietic lineages in a gene dosage-dependent and cell-autonomous manner. Ptpn11-deficient HSCs and progenitors undergo apoptosis concomitant with increased Noxa expression. Mutant HSCs/progenitors also show defective Erk and Akt activation in response to stem cell factor and diminished thrombopoietin-evoked Erk activation. Activated Kras alleviates the Ptpn11 requirement for colony formation by progenitors and cytokine/growth factor responsiveness of HSCs, indicating that Ras is functionally downstream of Shp2 in these cells. Thus, Shp2 plays a critical role in controlling the survival and maintenance of HSCs and immature progenitors in vivo.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21398220      PMCID: PMC3087477          DOI: 10.1182/blood-2010-11-319517

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  37 in total

1.  Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis.

Authors:  E Oda; R Ohki; H Murasawa; J Nemoto; T Shibue; T Yamashita; T Tokino; T Taniguchi; N Tanaka
Journal:  Science       Date:  2000-05-12       Impact factor: 47.728

2.  Apoptosis threshold set by Noxa and Mcl-1 after T cell activation regulates competitive selection of high-affinity clones.

Authors:  Felix M Wensveen; Klaas P J M van Gisbergen; Ingrid A M Derks; Carmen Gerlach; Ton N Schumacher; René A W van Lier; Eric Eldering
Journal:  Immunity       Date:  2010-06-25       Impact factor: 31.745

3.  The Caenorhabditis elegans EGL-15 signaling pathway implicates a DOS-like multisubstrate adaptor protein in fibroblast growth factor signal transduction.

Authors:  J L Schutzman; C Z Borland; J C Newman; M K Robinson; M Kokel; M J Stern
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

4.  Analysis of corkscrew signaling in the Drosophila epidermal growth factor receptor pathway during myogenesis.

Authors:  M R Johnson Hamlet; L A Perkins
Journal:  Genetics       Date:  2001-11       Impact factor: 4.562

5.  Inducible gene targeting in mice.

Authors:  R Kühn; F Schwenk; M Aguet; K Rajewsky
Journal:  Science       Date:  1995-09-08       Impact factor: 47.728

6.  A definitive role of Shp-2 tyrosine phosphatase in mediating embryonic stem cell differentiation and hematopoiesis.

Authors:  Rebecca J Chan; Scott A Johnson; Yanjun Li; Mervin C Yoder; Gen-Sheng Feng
Journal:  Blood       Date:  2003-06-05       Impact factor: 22.113

7.  The SH2-containing tyrosine phosphatase corkscrew is required during signaling by sevenless, Ras1 and Raf.

Authors:  J D Allard; H C Chang; R Herbst; H McNeill; M A Simon
Journal:  Development       Date:  1996-04       Impact factor: 6.868

8.  Control of cell fate determination by p21ras/Ras1, an essential component of torso signaling in Drosophila.

Authors:  X Lu; T B Chou; N G Williams; T Roberts; N Perrimon
Journal:  Genes Dev       Date:  1993-04       Impact factor: 11.361

9.  Hematopoietic stem cells engraft in mice with absolute efficiency.

Authors:  Patricia Benveniste; Claude Cantin; Deborah Hyam; Norman N Iscove
Journal:  Nat Immunol       Date:  2003-05-25       Impact factor: 25.606

10.  Shp2 regulates SRC family kinase activity and Ras/Erk activation by controlling Csk recruitment.

Authors:  Si Qing Zhang; Wentian Yang; Maria I Kontaridis; Trever G Bivona; Gengyun Wen; Toshiyuki Araki; Jincai Luo; Julie A Thompson; Burkhart L Schraven; Mark R Philips; Benjamin G Neel
Journal:  Mol Cell       Date:  2004-02-13       Impact factor: 17.970

View more
  48 in total

1.  The dynamic interplay between a PTK (Kit) and a PTP (Shp2) in hematopoietic stem and progenitor cells.

Authors:  Helen He Zhu; Gen-Sheng Feng
Journal:  Cell Cycle       Date:  2011-07-15       Impact factor: 4.534

2.  T cell activation is reduced by the catalytically inactive form of protein tyrosine phosphatase SHP-2.

Authors:  Baoxia Dong; Yubo Gao; Xuan Zheng; Guangxun Gao; Hongtao Gu; Xiequn Chen; Jinyi Zhang
Journal:  Int J Clin Exp Med       Date:  2015-04-15

3.  SHP2 tyrosine phosphatase stimulates CEBPA gene expression to mediate cytokine-dependent granulopoiesis.

Authors:  Li Zhang; Alan D Friedman
Journal:  Blood       Date:  2011-07-01       Impact factor: 22.113

4.  Role of SHP2 phosphatase in KIT-induced transformation: identification of SHP2 as a druggable target in diseases involving oncogenic KIT.

Authors:  Raghuveer Singh Mali; Peilin Ma; Li-Fan Zeng; Holly Martin; Baskar Ramdas; Yantao He; Emily Sims; Sarah Nabinger; Joydeep Ghosh; Namit Sharma; Veerendra Munugalavadla; Anindya Chatterjee; Shuo Li; George Sandusky; Andrew W Craig; Kevin D Bunting; Gen-Sheng Feng; Rebecca J Chan; Zhong-Yin Zhang; Reuben Kapur
Journal:  Blood       Date:  2012-07-17       Impact factor: 22.113

5.  Shp2 and Pten have antagonistic roles in myeloproliferation but cooperate to promote erythropoiesis in mammals.

Authors:  Helen He Zhu; Xiaolin Luo; Kaiqing Zhang; Jian Cui; Huifang Zhao; Zhongzhong Ji; Zhicheng Zhou; Jufang Yao; Lifan Zeng; Kaihong Ji; Wei-Qiang Gao; Zhong-Yin Zhang; Gen-Sheng Feng
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-12       Impact factor: 11.205

Review 6.  Shp2 function in hematopoietic stem cell biology and leukemogenesis.

Authors:  Sarah C Nabinger; Rebecca J Chan
Journal:  Curr Opin Hematol       Date:  2012-07       Impact factor: 3.284

7.  Correlation of mutation profile and response in patients with myelofibrosis treated with ruxolitinib.

Authors:  Keyur P Patel; Kate J Newberry; Rajyalakshmi Luthra; Elias Jabbour; Sherry Pierce; Jorge Cortes; Rajesh Singh; Meenakshi Mehrotra; Mark J Routbort; Madan Luthra; Taghi Manshouri; Fabio P Santos; Hagop Kantarjian; Srdan Verstovsek
Journal:  Blood       Date:  2015-06-29       Impact factor: 22.113

8.  Erk1 and Erk2 are required for maintenance of hematopoietic stem cells and adult hematopoiesis.

Authors:  Gordon Chan; Shengqing Gu; Benjamin G Neel
Journal:  Blood       Date:  2013-02-26       Impact factor: 22.113

9.  Lnk adaptor suppresses radiation resistance and radiation-induced B-cell malignancies by inhibiting IL-11 signaling.

Authors:  Igal Louria-Hayon; Catherine Frelin; Julie Ruston; Gerald Gish; Jing Jin; Michael M Kofler; Jean-Philippe Lambert; Hibret A Adissu; Michael Milyavsky; Robert Herrington; Mark D Minden; John E Dick; Anne-Claude Gingras; Norman N Iscove; Tony Pawson
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

10.  Runx1 Phosphorylation by Src Increases Trans-activation via Augmented Stability, Reduced Histone Deacetylase (HDAC) Binding, and Increased DNA Affinity, and Activated Runx1 Favors Granulopoiesis.

Authors:  Wan Yee Leong; Hong Guo; Ou Ma; Hui Huang; Alan B Cantor; Alan D Friedman
Journal:  J Biol Chem       Date:  2015-11-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.